Annexon (NasdaqGS:ANNX) Update / briefing March 18, 2026 02:00 PM ET Company ParticipantsBill Maughan - Managing Director of Equity ResearchCharles Wykoff - Chair of Clinical TrialsDarryl Wise - SVP of InvestmentsDoug Love - President and CEOEleonora Lad - Vice Chair of Clinical Research and Professor of OphthalmologyJamie Dananberg - Chief Medical OfficerLloyd Clark - SVP of Ophthalmology Strategy and InnovationSamantha Schaefer - Biotech Equity Research AssociateTazeen Ahmad - Managing Director in US Equi ...